MeSH 搜索器

Clinical Trials, Phase III as Topic

Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
推出的年份: 2008(1993)
副标题
树号: E05.318.372.250.250.220, N05.715.360.330.250.250.220, N06.850.520.450.250.250.220
MeSH 单一 ID: D017326
进入的组:
  • Clinical Trials, Phase 3 as Topic
  • Evaluation Studies, FDA Phase III as Topic
  • Drug Evaluation, FDA Phase III as Topic
  • Drug Evaluation, FDA Phase 3 as Topic
  • Evaluation Studies, FDA Phase 3 as Topic
早前的内容:
  • Clinical Trials (1980-1992)

留言 (0)

沒有登入
gif